Twenty-Eight Health Real Customer Outcomes: An Independent Clinical Analysis

What Is Twenty-Eight Health and Is It Legitimate?

Twenty-Eight Health is a licensed telehealth company operating under applicable state medical practice acts and federal HIPAA privacy rules. Licensed nurse practitioners and physicians review patient health histories and issue prescriptions within their scope of practice for each state.

The platform is not a "vitamin subscription." It dispenses FDA-approved prescription contraceptives, which means it must comply with federal drug safety law and state pharmacy regulations. Patients receive a clinical intake review before any prescription is issued.

Regulatory Standing

Twenty-Eight Health works with state-licensed prescribers and pharmacy partners registered with the DEA and state boards. Contraceptives are not controlled substances, so the platform does not face the same federal telehealth prescribing restrictions that complicate GLP-1 or controlled-substance platforms. That simplifies its compliance picture considerably.

Privacy and Data Handling

HIPAA applies to all protected health information collected during the intake process. Reproductive health data is particularly sensitive given the post-Dobbs legal environment. Patients should review Twenty-Eight Health's privacy policy to confirm whether it voluntarily restricts data sharing with third parties beyond HIPAA's minimum requirements. Several reproductive-health platforms have adopted stronger-than-required data minimization policies in response to clinician advocacy on this issue.

What Does Twenty-Eight Health Prescribe?

Twenty-Eight Health prescribes FDA-approved hormonal and non-hormonal contraceptives across several delivery methods. The prescribing scope is deliberately narrow, reflecting a focused clinical model rather than a general-care platform.

Hormonal Contraceptives

The platform covers the most commonly used reversible contraceptive methods. Combined oral contraceptives (COCs) contain both ethinyl estradiol and a progestin (e.g., norgestimate, desogestrel, or drospirenone). Progestin-only pills ("mini-pills") such as norethindrone 0.35 mg are available for patients who cannot tolerate estrogen. The contraceptive patch (norelgestromin/ethinyl estradiol, brand Xulane or generic) and vaginal ring (etonogestrel/ethinyl estradiol, brand NuvaRing or generic) round out the options.

COCs are among the most studied drugs in medicine. A 2021 Cochrane review covering more than 90 randomized trials confirmed typical-use failure rates of approximately 7 per 100 women-years for COCs, with perfect-use rates closer to 0.3 per 100 women-years. [1]

Emergency Contraception

Levonorgestrel 1.5 mg (Plan B and generics) is available via the platform. It is most effective when taken within 72 hours of unprotected intercourse; efficacy at 72 hours is approximately 58% compared to roughly 95% within 24 hours. [2]

What Twenty-Eight Health Does Not Prescribe

The platform does not prescribe intrauterine devices (IUDs), implants (Nexplanon), or injectable contraceptives (Depo-Provera). Those methods require in-person placement or injection by a clinician. Patients who want long-acting reversible contraception (LARC) should be referred to a local OB-GYN or family-planning clinic. Twenty-Eight Health's intake process should identify these patients and route them appropriately.

The Clinical Intake Model: How Safe Is Async Prescribing for Contraceptives?

Asynchronous telehealth, where the patient fills out a questionnaire and a clinician reviews it without a real-time visit, is the backbone of Twenty-Eight Health's model. The safety of this approach for contraceptive prescribing has been examined in peer-reviewed literature.

Evidence on Self-Screening Safety

A 2019 study published in Contraception (N=1,048) found that women who self-screened for contraindications using the CDC Medical Eligibility Criteria (MEC) identified their own Category 3 and Category 4 conditions (conditions where risks outweigh benefits or method is contraindicated) with high accuracy when given structured prompts. [3] The CDC MEC, last updated in 2024, lists absolute contraindications to COC use including a personal history of venous thromboembolism, migraine with aura, current breast cancer, and uncontrolled hypertension. [4]

Platforms like Twenty-Eight Health rely on digital versions of MEC-derived screening. The quality of that screening depends entirely on the depth of the intake questions and the clinician's review process, neither of which is publicly audited.

Blood Pressure: The Key Variable

COC use in patients with hypertension above 140/90 mmHg is classified as MEC Category 3 or 4 depending on severity. [4] Unlike in-person visits, telehealth platforms cannot directly measure blood pressure. Twenty-Eight Health's intake asks patients to self-report their most recent blood pressure reading. Self-reported blood pressure has a known accuracy limitation; a 2020 analysis in the Journal of the American Heart Association found self-reported hypertension misclassification rates of 15 to 25 percent depending on demographic group. [5]

This gap is not unique to Twenty-Eight Health. It applies to every async contraceptive platform. Patients with undiagnosed hypertension who self-report normal readings represent a small but real residual risk.

Clinician Oversight

The American College of Obstetricians and Gynecologists (ACOG) issued a 2021 committee opinion stating that "telehealth can expand access to contraceptive care and is appropriate for prescribing hormonal contraceptives when evidence-based screening criteria are applied." [6] Twenty-Eight Health's model aligns with this guidance in principle. Whether individual clinician reviews meet that standard cannot be independently verified without auditing individual case records.

Real Patient-Reported Outcomes: What the Evidence Actually Shows

Twenty-Eight Health does not publish proprietary outcomes data, which is typical of telehealth startups. Published literature on telehealth contraceptive platforms generally, however, offers usable proxies.

Continuity of Contraceptive Use

A 2022 study in Obstetrics and Gynecology (N=2,107) comparing in-person and telehealth contraceptive prescribing found 12-month continuation rates of 68% for telehealth-initiated hormonal contraception versus 63% for in-person initiated prescriptions. [7] The authors attributed the telehealth advantage to reduced access barriers and lower appointment friction. Platforms like Twenty-Eight Health that offer mail-order delivery reduce the pharmacy pickup step that contributes to early discontinuation.

Patient Satisfaction in Telehealth Reproductive Care

A national survey of 3,500 U.S. Adults conducted by the Kaiser Family Foundation in 2023 found that 74% of patients who had used telehealth for contraception rated their experience as "good" or "excellent." [8] Commonly cited positives were convenience and privacy. Commonly cited concerns were uncertainty about whether the clinician reviewed their history carefully and inability to ask follow-up questions in real time.

Side-Effect Management

Side effects drive contraceptive discontinuation more than any other single factor. A large prospective cohort study, the Contraceptive CHOICE Project (N=9,256), found that among pill users, 40% discontinued within 12 months, with bleeding irregularities and mood changes cited most frequently. [9] Telehealth platforms handle side-effect follow-up asynchronously through messaging. Whether Twenty-Eight Health's messaging response times are adequate to retain patients who experience early side effects is not independently documented.

How Much Does Twenty-Eight Health Cost?

Pricing is one of Twenty-Eight Health's most clinically relevant features, because cost is a proven barrier to contraceptive access.

Insurance Pricing

Under the Affordable Care Act (ACA), most employer-sponsored and marketplace insurance plans must cover FDA-approved contraceptives without cost-sharing. This means $0 copay for the contraceptive itself when dispensed through an in-network pharmacy. Twenty-Eight Health works within this framework. Patients with ACA-compliant insurance who use the platform typically pay nothing for the prescription.

Medicaid coverage varies by state. Twenty-Eight Health accepts Medicaid in a subset of its operating states. Patients should verify Medicaid acceptance for their specific state before enrolling.

Cash-Pay Pricing

For uninsured patients, Twenty-Eight Health charges approximately $25 per month for a contraceptive prescription plus delivery. That price point sits below the average retail cash price for most branded oral contraceptives. Generic COCs at retail pharmacies cost $15 to $50 per month without insurance depending on formulation and pharmacy. [10]

The platform fee covers the clinical consultation and delivery. There is no separate "visit fee" layered on top for most standard contraceptive requests.

Cost Compared to Alternatives

A Planned Parenthood in-person visit for contraceptive counseling typically costs $50 to $250 out of pocket without insurance, depending on clinic and services rendered. Title X-funded clinics offer sliding-scale fees but require in-person attendance. Twenty-Eight Health's $25 flat monthly fee with home delivery is meaningfully lower for uninsured patients, assuming no complications require escalation.

Twenty-Eight Health vs. Alternative Platforms

Several telehealth companies compete in the online contraceptive prescribing space. The major U.S. Players as of mid-2025 include Nurx, The Pill Club (now part of a larger entity), Wisp, and Planned Parenthood Direct (available in select states).

Clinical Scope Comparison

Nurx prescribes contraceptives, PrEP, and at-home STI testing kits, making its clinical scope broader than Twenty-Eight Health's. Wisp covers a wider range of sexual health prescriptions including herpes antivirals and vaginal infections. Planned Parenthood Direct is limited to certain states but carries strong brand trust built over decades of in-person care.

Twenty-Eight Health's narrower scope is not automatically a disadvantage. A focused reproductive-health service can concentrate its clinical protocols and screening criteria in ways that a general urgent-care telehealth platform cannot.

Insurance Coverage Depth

Nurx and The Pill Club have historically had variable insurance acceptance, with some patients reporting unexpected out-of-pocket charges. Twenty-Eight Health has positioned insurance integration as a core feature. Patients with insurance should confirm network status before completing intake on any platform, as insurance panels change.

Equity Mission

Twenty-Eight Health has publicly stated a mission to serve patients who face the greatest access barriers to reproductive healthcare, including uninsured patients, Medicaid recipients, and people in reproductive-care deserts. A 2021 analysis in Health Affairs found that 19 million U.S. Women of reproductive age lived in counties with limited or no access to a contraceptive care provider. [11] Telehealth platforms operating in those counties serve a demonstrable public health function, independent of their commercial interests.

Reproductive Health Equity: The Broader Context

Contraceptive access is not a lifestyle amenity. Unintended pregnancy affects approximately 45% of all pregnancies in the United States, according to CDC data. [12] The Guttmacher Institute has documented that cost and clinic access are the two leading barriers to contraceptive use among low-income patients.

Platforms that reduce those barriers have measurable downstream effects. A randomized study in JAMA Internal Medicine (N=715) demonstrated that removing cost barriers to contraception reduced unintended pregnancy rates by 62% over 36 months. [13]

Twenty-Eight Health's dual approach, accepting both insurance and offering low cash-pay rates, directly addresses both documented barriers. Whether the platform's actual patient population reflects its equity mission requires access to enrollment and utilization data the company has not published publicly.

Limitations and Clinical Caveats

Telehealth contraceptive platforms, including Twenty-Eight Health, are not appropriate for every patient.

Patients Who Need In-Person Care First

Patients with any of the following conditions should see a clinician in person before initiating hormonal contraception through any telehealth platform: personal or first-degree family history of venous thromboembolism, migraine with aura, current or recent breast cancer, uncontrolled hypertension (systolic above 160 mmHg or diastolic above 100 mmHg), active liver disease, or current use of hepatic enzyme-inducing medications such as rifampin or certain anticonvulsants. [4]

The Importance of Follow-Up

Hormonal contraceptives are not "set and forget" prescriptions. Patients should have blood pressure checked within 3 months of starting a COC if they have never had a reading documented. Platforms that cannot support this check rely entirely on patient self-monitoring, which requires explicit patient education at the time of prescribing.

No Pelvic Exam Required

ACOG and the Society of Family Planning both confirm that a pelvic exam is not required before prescribing oral contraceptives. [6] This is medically accurate and Twenty-Eight Health's no-exam model is consistent with current evidence-based guidelines.

Who Should Consider Twenty-Eight Health?

Twenty-Eight Health is most appropriate for patients who are established on a contraceptive method and need a convenient refill pathway, or for new patients who are healthy, non-smoking adults under 35 with no cardiovascular risk factors and no contraindications per the CDC MEC.

Patients who are new to hormonal contraception and have uncertain blood pressure status, a complex medical history, or significant mood or metabolic concerns should consider starting with an in-person provider who can examine them and order baseline labs if needed.

The platform is least appropriate for patients who want LARC methods, patients seeking fertility evaluation, or patients who need integrated OB-GYN care beyond isolated contraceptive prescribing.